Translating the role of vitamin D₃ in infectious diseases

References

• Adams JS, Sharma OP, Gacad MA, Singer FR. (1983). Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest, 72, 1856–1860.
   PubMed Web of Science ®Google Scholar
• Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. (2009). 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine, 45, 190–197.
   PubMed Web of Science ®Google Scholar
• Aloia JF, Li-Ng M. (2007). Re: epidemic influenza and vitamin D. Epidemiol Infect, 135, 1095–1096.
   PubMed Web of Science ®Google Scholar
• Alroy I, Towers TL, Freedman LP. (1995). Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol, 15, 5789–5799.
   PubMed Web of Science ®Google Scholar
• Arpadi SM, McMahon D, Abrams EJ, Bamji M, Purswani M, Engelson ES, Horlick M, Shane E. (2009). Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics, 123, e121–e126.
   PubMed Web of Science ®Google Scholar
• Asakura H, Aoshima K, Suga Y, Yamazaki M, Morishita E, Saito M, Miyamoto K, Nakao S. (2001). Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models. Thromb Haemost, 85, 287–290.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL, Simon KC. (2010). Vitamin D and multiple sclerosis. Lancet Neurol, 9, 599–612.
   PubMed Web of Science ®Google Scholar
• Baeke F, van Etten E, Gysemans C, Overbergh L, Mathieu C. (2008). Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities. Mol Aspects Med, 29, 376–387.
   PubMedGoogle Scholar
• Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O’Garra A. (2002). In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med, 195, 603–616.
   PubMed Web of Science ®Google Scholar
• Berer A, Stöckl J, Majdic O, Wagner T, Kollars M, Lechner K, Geissler K, Oehler L. (2000). 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol, 28, 575–583.
   PubMed Web of Science ®Google Scholar
• Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. (1983). Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab, 57, 1308–1310.
   PubMed Web of Science ®Google Scholar
• Bhalla AK, Amento EP, Krane SM. (1986). Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol, 98, 311–322.
   PubMed Web of Science ®Google Scholar
• Biswas P, Mengozzi M, Mantelli B, Delfanti F, Brambilla A, Vicenzi E, Poli G. (1998). 1,25-Dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-kappaB-independent enhancement of viral replication. J Virol, 72, 8380–8383.
   Google Scholar
• Blum M, Dallal GE, Dawson-Hughes B. (2008). Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr, 27, 274–279.
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Krohn MA, Simhan HN. (2009). Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr, 139, 1157–1161.
   PubMed Web of Science ®Google Scholar
• Bonilla E. (1954). Treatment of chromoblastomycosis with calciferol; report of three cases. AMA Arch Derm Syphilol, 70, 666–667.
   PubMedGoogle Scholar
• Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. (2001). 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol, 167, 4974–4980.
   PubMed Web of Science ®Google Scholar
• Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. (2010). Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care, 33, 2244–2249.
   Google Scholar
• Bukoski RD, Xue H. (1993). On the vascular inotropic action of 1,25-(OH)2 vitamin D3. Am J Hypertens, 6, 388–396.
   PubMedGoogle Scholar
• Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. (2006). Epidemic influenza and vitamin D. Epidemiol Infect, 134, 1129–1140.
   PubMed Web of Science ®Google Scholar
• Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D. (2010). Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate, 71, 368–372.
   PubMed Web of Science ®Google Scholar
• Colin EM, Asmawidjaja PS, van Hamburg JP, Mus AM, van Driel M, Hazes JM, van Leeuwen JP, Lubberts E. (2010). 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum, 62, 132–142.
   PubMed Web of Science ®Google Scholar
• Conesa-Botella A, Florence E, Lynen L, Colebunders R, Menten J, Moreno-Reyes R. (2010). Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther, 7, 40.
   PubMed Web of Science ®Google Scholar
• Conesa-Botella A, Mathieu C, Colebunders R, Moreno-Reyes R, van Etten E, Lynen L, Kestens L. (2009). Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome? AIDS Res Ther, 6, 4.
   PubMedGoogle Scholar
• Connor RI, Rigby WF. (1991). 1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem Biophys Res Commun, 176, 852–859.
   PubMed Web of Science ®Google Scholar
• Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. (2003). HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS, 17, 513–520.
   PubMed Web of Science ®Google Scholar
• Crowle AJ, Ross EJ, May MH. (1987). Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun, 55, 2945–2950.
   PubMed Web of Science ®Google Scholar
• D’Souza MP, Harden VA. (1996). Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat Med, 2, 1293–1300.
   PubMed Web of Science ®Google Scholar
• Damsker JM, Hansen AM, Caspi RR. (2010). Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci, 1183, 211–221.
   PubMed Web of Science ®Google Scholar
• Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. (2008). Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther, 324, 23–33.
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N. (2010). IOF position statement: vitamin D recommendations for older adults. Osteoporos Int, 21, 1151–1154.
   PubMed Web of Science ®Google Scholar
• Dickie LJ, Church LD, Coulthard LR, Mathews RJ, Emery P, McDermott MF. (2010). Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology (Oxford), 49, 1466–1471.
   PubMed Web of Science ®Google Scholar
• Dowling GB, Thomas EW, Wallace HJ. (1946). Lupus vulgaris treated with calciferol. Proc R Soc Lond, B, Biol Sci, 39, 225–227.
   Google Scholar
• Durazo-Arvizu RA, Dawson-Hughes B, Sempos CT, Yetley EA, Looker AC, Cao G, Harris SS, Burt VL, Carriquiry AL, Picciano MF. (2010). Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr, 140, 595–599.
   PubMed Web of Science ®Google Scholar
• Ellman P, Anderson KH. (1948). Calciferol in tuberculous peritonitis with disseminated tuberculosis. Br Med J, 1, 394.
   Google Scholar
• Feeny PJ, Sandiland EL, Franklin LM. (1947). Calciferol in tuberculosis; review of 150 cases of lupus vulgaris. Lancet, 1, 438–443.
   Google Scholar
• Fielding J, Maloney JJ. (1951). Calciferol, streptomycin, and para-aminosalicylic acid in pulmonary tuberculosis. Lancet, 2, 614–617.
   Google Scholar
• Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. (2011). Improvement in Vitamin D Deficiency Following Antiretroviral Regime Change: Results from the MONET Trial. AIDS Res Hum Retroviruses, 29–34
   Google Scholar
• Gibney KB, MacGregor L, Leder K, Torresi J, Marshall C, Ebeling PR, Biggs BA. (2008). Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis, 46, 443–446.
   PubMed Web of Science ®Google Scholar
• Ginde AA, Mansbach JM, Camargo CA Jr. (2009). Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med, 169, 384–390.
   PubMed Web of Science ®Google Scholar
• Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. (2007). Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract, 77, 47–57.
   PubMed Web of Science ®Google Scholar
• Grant WB. (2008). Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr Infect Dis J, 27, 853.
   PubMed Web of Science ®Google Scholar
• Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. (2010). Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol, 184, 965–974.
   PubMed Web of Science ®Google Scholar
• Haug C, Müller F, Aukrust P, Frøland SS. (1994). Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis, 169, 889–893.
   PubMed Web of Science ®Google Scholar
• Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS. (1998). Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab, 83, 3832–3838.
   PubMed Web of Science ®Google Scholar
• Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. (2003). Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr, 77, 204–210.
   PubMed Web of Science ®Google Scholar
• Henry HL, Bouillon R, Norman AW, Gallagher JC, Lips P, Heaney RP, Vieth R, Pettifor JM, Dawson-Hughes B, Lamberg-Allardt CJ, Ebeling PR. (2010). 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol, 121, 4–6.
   PubMed Web of Science ®Google Scholar
• Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R. (2003). Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol, 170, 5382–5390.
   PubMed Web of Science ®Google Scholar
• Hmama Z, Sendide K, Talal A, Garcia R, Dobos K, Reiner NE. (2004). Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J Cell Sci, 117, 2131–2140.
   PubMed Web of Science ®Google Scholar
• Holick MF. (2007). Vitamin D deficiency. N Engl J Med, 357, 266–281.
   PubMed Web of Science ®Google Scholar
• Hollis BW. (1996). Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int, 58, 4–5.
   PubMed Web of Science ®Google Scholar
• Horiuchi H, Nagata I, Komoriya K. (1991). Protective effect of vitamin D3 analogues on endotoxin shock in mice. Agents Actions, 33, 343–348.
   PubMedGoogle Scholar
• Hussain I, Rashid T, Haroon TS. (2002). Parenteral vitamin D(3) and oral terbinafine for refractory chromoblastomycosis. Br J Dermatol, 146, 704.
   PubMed Web of Science ®Google Scholar
• Imazeki I, Matsuzaki J, Tsuji K, Nishimura T. (2006). Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res, 27, 1–9.
   PubMed Web of Science ®Google Scholar
• Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM. (2009). 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol, 183, 5458–5467.
   PubMed Web of Science ®Google Scholar
• Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, Tangpricha V. (2009). Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med, 7, 28.
   PubMed Web of Science ®Google Scholar
• Jordan SC, Toyoda M, Prehn J, Lemire JM, Sakai R, Adams JS. (1989). 1,25-Dihydroxyvitamin-D3 regulation of interleukin-2 and interleukin-2 receptor levels and gene expression in human T cells. Mol Immunol, 26, 979–984.
   PubMedGoogle Scholar
• Kampman MT, Brustad M. (2008). Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway. Neuroepidemiology, 30, 140–146.
   PubMed Web of Science ®Google Scholar
• Khoo AL, Chai L, Koenen H, Oosting M, Steinmeyer A, Zuegel U, Joosten I, Netea M, van der Ven A. (2011a). Vitamin D3 Down-regulates Proinflammatory Cytokine Response to Mycobacterium tuberculosis Through Pattern Recognition Receptors while Inducing Protective Cathelicidin Production. pp. 294–300.
   Google Scholar
• Khoo AL, Chai LY, Koenen HJ, Sweep FC, Joosten I, Netea MG, van der Ven AJ. (2011b). Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol, 164, 72–79.
   PubMed Web of Science ®Google Scholar
• Khoo AL, Chai LY, Koenen HJ, Kullberg BJ, Joosten I, van der Ven AJ, Netea MG. (2011c). 1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses. J Infect Dis, 203, 122–130.
   PubMed Web of Science ®Google Scholar
• Kizaki M, Ikeda Y, Simon KJ, Nanjo M, Koeffler HP. (1993). Effect of 1,25-dihydroxyvitamin D3 and its analogs on human immunodeficiency virus infection in monocytes/macrophages. Leukemia, 7, 1525–1530.
   PubMed Web of Science ®Google Scholar
• Kreindler JL, Steele C, Nguyen N, Chan YR, Pilewski JM, Alcorn JF, Vyas YM, Aujla SJ, Finelli P, Blanchard M, Zeigler SF, Logar A, Hartigan E, Kurs-Lasky M, Rockette H, Ray A, Kolls JK. (2010). Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest, 120, 3242–3254.
   PubMed Web of Science ®Google Scholar
• Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. (1993). 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood, 82, 1300–1307.
   PubMed Web of Science ®Google Scholar
• Kriesel JD, Spruance J. (1999). Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine, 17, 1883–1888.
   PubMed Web of Science ®Google Scholar
• Krishnan AV, Trump DL, Johnson CS, Feldman D. (2010). The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am, 39, 401–18, table of contents.
   Google Scholar
• Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H. (2010). Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis, 202, 809–814.
   PubMed Web of Science ®Google Scholar
• Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T. (2007). An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr, 86, 714–717.
   PubMed Web of Science ®Google Scholar
• Lemire JM, Adams JS, Sakai R, Jordan SC. (1984). 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest, 74, 657–661.
   PubMed Web of Science ®Google Scholar
• Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N. (2009). A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect, 137, 1396–1404.
   PubMed Web of Science ®Google Scholar
• Lips P. (2006). Vitamin D physiology. Prog Biophys Mol Biol, 92, 4–8.
   PubMed Web of Science ®Google Scholar
• Lips P. (2007). Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res, 22, 1668–1671.
   PubMed Web of Science ®Google Scholar
• Lips P. (2010). Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol, 121:297–300
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. (2006). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 311, 1770–1773.
   PubMed Web of Science ®Google Scholar
• Locardi C, Petrini C, Boccoli G, Testa U, Dieffenbach C, Buttò S, Belardelli F. (1990). Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production. J Virol, 64, 5874–5882.
   PubMed Web of Science ®Google Scholar
• Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR. (2008). Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med, 205, 799–810.
   PubMed Web of Science ®Google Scholar
• Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G. (2004). Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging, 48, 39–48.
   PubMed Web of Science ®Google Scholar
• Mahon BD, Wittke A, Weaver V, Cantorna MT. (2003). The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem, 89, 922–932.
   PubMed Web of Science ®Google Scholar
• Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK, Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V, Drobniewski FA, Eldridge SM, Griffiths CJ. (2011). High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet, 377, 242–250.
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, Rainbow SJ, Berry JL, Griffiths CJ. (2007). A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med, 176, 208–213.
   PubMed Web of Science ®Google Scholar
• Mehta S, Giovannucci E, Mugusi FM, Spiegelman D, Aboud S, Hertzmark E, Msamanga GI, Hunter D, Fawzi WW. (2010). Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE, 5, e8770.
   PubMed Web of Science ®Google Scholar
• Møller S, Laigaard F, Olgaard K, Hemmingsen C. (2007). Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis. Int J Med Sci, 4, 190–195.
   PubMedGoogle Scholar
• Morcos MM, Gabr AA, Samuel S, Kamel M, el Baz M, el Beshry M, Michail RR. (1998). Vitamin D administration to tuberculous children and its value. Boll Chim Farm, 137, 157–164.
   PubMedGoogle Scholar
• Nieto G, Barber Y, Rubio MC, Rubio M, Fibla J. (2004). Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients. J Steroid Biochem Mol Biol, 89-90, 199–207.
   PubMed Web of Science ®Google Scholar
• Nnoaham KE, Clarke A. (2008). Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol, 37, 113–119.
   PubMed Web of Science ®Google Scholar
• Nursyam EW, Amin Z, Rumende CM. (2006). The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones, 38, 3–5.
   PubMedGoogle Scholar
• Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D, Casteels KM, Laureys J, Bouillon R, Mathieu C. (2000). 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes, 49, 1301–1307.
   PubMed Web of Science ®Google Scholar
• Pauza CD, Kornbluth R, Emau P, Richman DD, Deftos LJ. (1993). Vitamin D3 compounds regulate human immunodeficiency virus type 1 replication in U937 monoblastoid cells and in monocyte-derived macrophages. J Leukoc Biol, 53, 157–164.
   Google Scholar
• Penna G, Adorini L. (2000). 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol, 164, 2405–2411.
   PubMed Web of Science ®Google Scholar
• Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, Adorini L. (2007). 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol, 178, 145–153.
   PubMed Web of Science ®Google Scholar
• Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxí A. (2010). Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology, 51, 1158–1167.
   PubMed Web of Science ®Google Scholar
• Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. (2000). Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol, 164, 4443–4451.
   PubMed Web of Science ®Google Scholar
• Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. (1983). 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science, 221, 1181–1183.
   PubMed Web of Science ®Google Scholar
• Qi XP, Li P, Li G, Sun Z, Li JS. (2008). 1,25-dihydroxyvitamin D(3) regulates LPS-induced cytokine production and reduces mortality in rats. World J Gastroenterol, 14, 3897–3902.
   Google Scholar
• Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC. (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res, 20, 1352–1360.
   PubMed Web of Science ®Google Scholar
• Rigby WF, Stacy T, Fanger MW. (1984). Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest, 74, 1451–1455.
   PubMed Web of Science ®Google Scholar
• Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, Stanford J. (1986). Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology, 57, 159–163.
   PubMed Web of Science ®Google Scholar
• Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. (2010). Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE, 5, e11088.
   PubMed Web of Science ®Google Scholar
• Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zügel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A. (2006). Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol, 36, 361–370.
   PubMed Web of Science ®Google Scholar
• Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC. (2007). DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol, 8, 285–293.
   PubMed Web of Science ®Google Scholar
• Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. (2007). Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax, 62, 1003–1007.
   PubMed Web of Science ®Google Scholar
• Skolnik PR, Jahn B, Wang MZ, Rota TR, Hirsch MS, Krane SM. (1991). Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol. Proc Natl Acad Sci USA, 88, 6632–6636.
   Google Scholar
• Sly LM, Lopez M, Nauseef WM, Reiner NE. (2001). 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem, 276, 35482–35493.
   PubMed Web of Science ®Google Scholar
• Talat N, Perry S, Parsonnet J, Dawood G, Hussain R. (2010). Vitamin d deficiency and tuberculosis progression. Emerging Infect Dis, 16, 853–855.
   PubMed Web of Science ®Google Scholar
• Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS, Su SB, Chan CC, Adorini L, Caspi RR. (2009). Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol, 182, 4624–4632.
   PubMed Web of Science ®Google Scholar
• Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. (1998). Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr, 68, 854–858.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2007). Trends in tuberculosis–United States. MMWR Morb Mortal Wkly Rep, 57, 281–285.
   Google Scholar
• Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. (2009). Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol, 39, 3147–3159.
   PubMed Web of Science ®Google Scholar
• Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. (2010). Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr, 91, 1255–1260.
   PubMed Web of Science ®Google Scholar
• Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, Burger DM, Bravenboer B, Koopmans PP, Van Der Ven AJ. (2008). Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses, 24, 1375–1382.
   PubMed Web of Science ®Google Scholar
• van Crevel R, Ottenhoff TH, van der Meer JW. (2002). Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev, 15, 294–309.
   PubMed Web of Science ®Google Scholar
• Veldman CM, Cantorna MT, DeLuca HF. (2000). Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys, 374, 334–338.
   PubMed Web of Science ®Google Scholar
• Vieth R. (1999). Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr, 69, 842–856.
   PubMed Web of Science ®Google Scholar
• Vieth R, Chan PC, MacFarlane GD. (2001). Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr, 73, 288–294.
   PubMed Web of Science ®Google Scholar
• Villamor E. (2006). A potential role for vitamin D on HIV infection? Nutr Rev, 64, 226–233.
   PubMed Web of Science ®Google Scholar
• von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. (2010). Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol, 11, 344–349.
   PubMed Web of Science ®Google Scholar
• Webb AR, Holick MF. (1988). The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr, 8, 375–399.
   PubMed Web of Science ®Google Scholar
• Webster NR, Galley HF. (2009). Immunomodulation in the critically ill. Br J Anaesth, 103, 70–81.
   PubMed Web of Science ®Google Scholar
• Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M. (2009). Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med, 179, 843–850.
   PubMed Web of Science ®Google Scholar
• Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, Aaby P, Andersen PL, Glerup H, Sodemann M. (2007). Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr, 86, 1376–1383.
   PubMed Web of Science ®Google Scholar
• WHO Global tuberculosis control-epidemiology, strategy, financing. WHO Report 2009. Geneva: World Health Organisation.
   Google Scholar
• Williams B, Williams AJ, Anderson ST. (2008). Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J, 27, 941–942.
   PubMed Web of Science ®Google Scholar
• Williams CJB. (1849). Cod Liver oil in phthisis. London J Med, 1, 1–18.
   Google Scholar
• Xu H, Soruri A, Gieseler RK, Peters JH. (1993). 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand J Immunol, 38, 535–540.
   PubMed Web of Science ®Google Scholar
• Yusupov E, Li-Ng M, Pollack S, Yeh JK, Mikhail M, Aloia JF. (2010). Vitamin d and serum cytokines in a randomized clinical trial. Int J Endocrinol, 2010. pii: 305054.
   Google Scholar